{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-148905","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2025-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.762175+00:00","generated_at":"2026-05-18T18:08:38.357381+00:00","sec_items":["5.02","5.07","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aligos stockholders approve charter amendments increasing authorized shares 5x and 2020 Plan share reserve by 1M","bullets":["Stockholders approved increase in authorized voting common stock from 20M to 100M shares.","Stockholders approved increase in authorized non-voting common stock from 800k to 15.8M shares.","Stockholders approved amendment to 2020 Plan adding 1M shares to the share reserve.","All three Class II director nominees (Hirth, Preston, Chavez) were elected with ~2.16M votes for.","Ratification of Ernst & Young as independent auditor for FY2025 approved with 3.43M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-148905","json":"https://secwatch.observer/filing/0001193125-25-148905.json","markdown":"https://secwatch.observer/filing/0001193125-25-148905.md","text":"https://secwatch.observer/filing/0001193125-25-148905.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312525148905/0001193125-25-148905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312525148905/d98914d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T18:08:38.357381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d739cd53cdb3a6369575efc4da2ac298c9d8091","claim":"Aligos Therapeutics, Inc.: Increased authorized shares of voting common stock from 20,000,000 to 100,000,000 and non-voting common stock from 800,000 to 15,800,000 (effective 2025-06-25).","evidence_excerpt":"The increase in the number of authorized shares voting common stock and non-voting common stock was effected pursuant to a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) filed with the Secretary of State of the State of Delaware on June 25, 2025 and was effective as of such date.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312525148905/0001193125-25-148905-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-25"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}